Dragon exploration system on marine sponge compounds interactions by unknown
Sagar et al. Journal of Cheminformatics 2013, 5:11
http://www.jcheminf.com/content/5/1/11DATABASE Open AccessDragon exploration system on marine sponge
compounds interactions
Sunil Sagar, Mandeep Kaur, Aleksandar Radovanovic and Vladimir B Bajic*Abstract
Background: Natural products are considered a rich source of new chemical structures that may lead to the
therapeutic agents in all major disease areas. About 50% of the drugs introduced in the market in the last 20 years
were natural products/derivatives or natural products mimics, which clearly shows the influence of natural products
in drug discovery.
Results: In an effort to further support the research in this field, we have developed an integrative knowledge base
on Marine Sponge Compounds Interactions (Dragon Exploration System on Marine Sponge Compounds
Interactions - DESMSCI) as a web resource. This knowledge base provides information about the associations of the
sponge compounds with different biological concepts such as human genes or proteins, diseases, as well as
pathways, based on the literature information available in PubMed and information deposited in several other
databases. As such, DESMSCI is aimed as a research support resource for problems on the utilization of marine
sponge compounds. DESMSCI allows visualization of relationships between different chemical compounds and
biological concepts through textual and tabular views, graphs and relational networks. In addition, DESMSCI has
built in hypotheses discovery module that generates potentially new/interesting associations among different
biomedical concepts. We also present a case study derived from the hypotheses generated by DESMSCI which
provides a possible novel mode of action for variolins in Alzheimer’s disease.
Conclusion: DESMSCI is the first publicly available (http://www.cbrc.kaust.edu.sa/desmsci) comprehensive resource
where users can explore information, compiled by text- and data-mining approaches, on biological and chemical
data related to sponge compounds.
Keywords: Sponge compounds interactions, Natural products, Text-mining, Information integration, Knowledge baseBackground
Natural products are chemical compounds that originate
from living organisms and play a major role in the drug
discovery and development process. The importance of
natural products in drug discovery has been discussed in
several reviews and reports [1-5]. About 200,000 natural
compounds are currently known [6]. The chemical di-
versity of natural compounds, especially the diversity of
scaffolds and the large number of chiral centers repre-
sent a basis for their use in drug therapy. About 50% of
the drugs introduced in the market during the last 20
years are derived directly or indirectly from natural
products [7]. A total of 1,184 new approved drugs have
been identified covering all diseases/countries/sources in* Correspondence: vladimir.bajic@kaust.edu.sa
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reproduction in any medium, provided the orthe years 01/1981-06/2006. Out of these, only 30% were
synthetic in origin, which demonstrates the influence of
natural products/derivatives/natural product mimics on
drug discovery process [8].
The marine organisms adapted to unusual conditions
of higher salt content, low or zero light, unusually low
or high temperature and pressure, have offered a num-
ber of lead bioactive molecules with unique novel
structures and distinct biological activities. Marine
sponges have been considered a valuable source of
bioactive molecules with different pharmacological
activities. Sponges produce a wide array of secondary
metabolites ranging from derivatives of amino acids and
nucleosides to porphyrins, terpenoids macrolids, sterols,
and others. Reports of isolation and identification
of natural products from marine sponges are being
published since early 1950’s. The isolation andl Ltd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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from the Caribbean sponge Tethya crypta [9-11], led to
the discovery of close analogues, cytosine arabinoside or
Ara-C, as a potent antileukemic agent and adenine
arabinoside or Ara-A, an antiviral compound, as com-
mercial drugs. The sponge-derived apoptosis-inducing
lead compounds that have potential use in cancer treat-
ment have been described in a recent review [12].
The investigation of several sponge compounds in
clinical trials (Table 1) for various diseases proved the
significance of sponges as an important source organism
in the drug discovery [13]. Due to the importance of the
sponges and their bioactive compounds, the voluminous
research work in this area has generated a plethora
of published scientific reports. A query in PubMed
database (http://www.ncbi.nlm.nih.gov) using keywords
“porifera OR sponge OR sponges” retrieved 16,023
abstracts (31 December, 2012).
The significance of sponge bioactive compounds in the
drug discovery process and the lack of the public re-
source with the relevant information, motivated us to
develop Dragon Exploration System on Marine Sponge
Compounds Interactions (DESMSCI) as a public web-
based knowledge base that integrates and allows explor-
ation of information about sponge natural products and
their potential biological and chemical associations. It is
compiled from the published literature available in
PubMed and complemented by the information from 25
other resources (Table 2). DESMSCI is the first publicly
available, fully searchable, web-enabled knowledge base,
where the information related to the sponge natural
products can be explored at molecular levels, providing
insights into related or affected human genes and
proteins, diseases, and associated biological pathways, as
well as potential mutual links among these entities. The
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Bengamide derivative Jaspis sp
Girolline Pseudaxinyssa cantharella(DES), a biomedical text mining and data mining system.
DES has been previously used as the engine in creation
of a number of topic-specific knowledge bases [15-18].
DESMSCI Resource
DESMSCI knowledge base is a resource that is compiled
using as its primary engine, the KAUST-customized
version of Dragon Exploration System (DES). Original
DES is a proprietary text-mining and data-mining tool
from OrionCell (http://www.orioncell.org). The titles and
abstract of PubMed records are downloaded and indexed
using several dictionaries. Each of the dictionaries consists
of curated names and symbols and their variants custom-
ary for the specific types of entities (Table 3). For the data
integration purposes the MRS [19] was deployed. Data
was downloaded from 25 sources and indexed, producing
more than 76,000,000 records (Table 2). The data are
linked to annotated terms on-demand basis.
DESMSCI database was built on 31 December,
2012, with a document collection consisting of 16,023
abstracts downloaded from PubMed using “porifera
OR sponge OR sponges” as a query. Annotation
terms we used (Table 3) were from the following
dictionaries: “Sponge compounds”, “Human genes and
proteins”, “Mode of action”, “Pathways”, and “Disease
concepts”. The dictionary of “Sponge compounds”
contains manually curated 3,050 sponge compounds
(including synonyms), compiled from the published litera-
ture. The dictionary of genes and proteins contains
269,908 variants of entities covering the names, symbols,
aliases, previous names and previously used symbols of
human genes and proteins. The DES engine performed
annotation and created indexes of terms, terms pairs and
clustering of PubMed articles. Finally, DESMSCI web
interface was built by using DES customizable modules.
Data integration to local MRS installation was implementedeclinical trials
Disease Status
Cancer Phase I











Table 2 External databases used for data integration
Database URL Number of records
Chemical Entities of Biological Interest (ChEBI) http://www.ebi.ac.uk/chebi/init.do 38,580
ChEBI Ontology http://www.ebi.ac.uk/chebi/ 29,974
Enzyme http://ca.expasy.org/enzyme/ 5,418
Gene http://www.ncbi.nlm.nih.gov/gene 892,7911
Functional association data/networks (GeneMania) http://genemania.org/ 21,084
GO http://www.geneontology.org/ 34,940
GOA http://www.ebi.ac.uk/GOA/ 11,300,749
HUGO Gene Nomenclature http://www.genenames.org/ 35,795
Human Major Histocompatibility Complex http://www.ebi.ac.uk/imgt/hla/ 6,939

















Uniprot: UniProtKB/Swiss-Prot, UniProtKB/TrEMBL http://www.uniprot.org/ 17,035,495
Total Records 76,644,041
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dist/MRS-Client/].
The details about the methods applied by DES, how to
use the knowledge base and other relevant details are
provided in the documentation (http://www.cbrc.kaust.
edu.sa/desmsci/desmsci.pdf). The accuracy of the inte-
grated data was evaluated earlier in Sagar et al. [18] inTable 3 Dictionaries used for text mining during creation
of MSCI
Dictionary Number of terms Number of terms found




Mode of action 427 284
Pathways 3,717 58
Sponge Compounds 3,050 517
Total: 5 dictionaries Total: 361,384 Total: 7,254terms of precision (ability to identify the correct entities of
a specific type in PubMed abstracts relative to all identi-
fied entities of that type) and recall (the ability to identify
correct entities of a specific types present in the abstracts
relative to all entities of that type present in the abstracts)
and were found to be in the range of 81%–100% for differ-
ent categories, with an average F-measure of 92.9%. In an-
other report from our group, precison and recall were in
ranged from 78%–99% and 87%–100% [15]. A brief com-
parison with PolySearch [20], a web based text-mining
system, has also been reported [18]. However, these accur-
acy assessments can only be used as a guide and not as a
claim of absolute accuracy of the system.
Generation of text-mined and data-mined reports
DESMSCI contains query engine for the processing of
user’s queries. The system uses a set of abstracts
(obtained as a result of querying PubMed) and mines
these abstracts for the presence of terms listed in the
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present in the dictionaries are mapped to only that set
of abstracts. These mapped concepts are further used to
generate results that users see. It is important to under-
stand the work-flow of the process and to know how the
system works (Figure 1). The results of queries to
DESMSCI are presented in the form of tables or networks
which enable users to view the associations of a chemical
compound of interest with other biological concepts, such
as genes, proteins, diseases, pathways, etc. The links to
other external databases are provided that enables users
to explore the entity of interest in several external
resources (to study structure, function etc.). DESMSCI
also provides search options through the use of simple
logical operators "AND", "OR" and "NOT" that further
allow users an easier and direct access to each of the
reports. Simple association networks can be generated
for each of the identified concepts. A user-chosen con-
cept represents a center node for such a network. This
concept is connected to other concepts based on the
co-occurrence metrics. Edge connects two concepts
co-occurring in same abstracts and carries a weight
representative of the number of those abstracts.
Networks can be expanded or shrunk by selecting
various weight thresholds and subsets of dictionaries.
This is a convenient and efficient method to explore
huge amounts of literature data in shorter time and to
visualize the important associations among different
terms in an easy to follow graphical representations.
This functioning of the text-mining modules is based on












Figure 1 An overview of the text mining methodology.Hypothesis generation
Hypothesis generation is one of the most useful features
in DESMSCI. It allows users to infer potentially new/
interesting relationships among different concepts. The
module is based on Swanson’s ABC model [22]. It would
be very difficult if not impossible to manually extract
the associations between the concepts (which do not
appear in the same document), to infer potentially new
hypotheses, especially with the large amount of available
concepts and literature. DESMSCI allows for the inspec-
tion of automatically generated hypotheses and their
validity by retrieving the PubMed document(s) related
to the concepts linked through the hypothesis. The ini-
tial hint that the association between the two concepts
may be a candidate for a hypothesis appears in the case
when there is no connection (co-occurrence in the same
PubMed entry) of the concepts found in the analyzed
set of PubMed entries. DESMSCI provides for the further
inspection if the same two concepts co-occur in the same
PubMed entry by querying the whole PubMed (22,000,000
+ entries). If no PubMed document containing both of the
terms is found, it suggests a possible new association be-
tween such concepts, a hypothesis for further exploration.
Case studies
Variolins for preventing neurodegeneration in
Alzheimer’s disease
According to hypothesis generated by DESMSCI (Figure 2),
the term ‘variolins’ from “Sponge compounds” dictionary is
linked to the term ‘cyclin’ from “Human Genes and










Figure 2 Hypotheses describing links between ‘Variolins’ and ‘Disease concepts’ through ‘Cyclin’ in human genes and protein
dictionary. The interactions are based on co-occurrence of two entities in relevant PubMed literature.
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concepts” dictionary via two abstracts. On searching the
whole PubMed using the “test” button for the co-occurence
of terms ‘variolins’ and ‘Alzheimer’s disease’, no PubMed
record with such two terms was available. Thus, it was not
possible to establish a link between variolins and AD. We
further explored the underlying biology to search for any in-
direct link between these two concepts and to check the
validity of the hypothesis generated.
Variolins are anti-tumor marine alkaloids isolated
from a rare Antarctic sponge Kirkpatrickia Varialosa in
1994 [23]. Variolin-B (VAR-B) was most cytotoxic
among the four compounds isolated from sponge and
later derivatives of variolins were synthesized to en-
hance aqueous stability as well as their anti-cancer ac-
tivities [24]. The studies on a derivative (dVAR-B) of
VAR-B showed that variolins are CDK (cyclin-dependent
kinases) inhibitors and induce apoptosis via p53 independ-
ent mechanism [25]. Cyclins, CDKs and cyclin-dependent
kinase inhibitors (CKIs) are cell cycle regulatory proteins
that control cell cycle transition from one phase to
another (G1, S and G2). Cyclins and CDKs form
heterodimers leading to progression or inhibition of cell
cycle and these pairs are further inhibited or inactivated
by small CKI peptides. The cell cycle deregulation leads to
neurogeneration. In neurons, cell cycle normally does notprogress beyond G1 phase checkpoint, but in AD, cell cycle
progresses to G2 phase that leads the cell to death [26], and
also drives the formation of neurofibrillary tangles and
amyloid plaques [27-29]. This leads to neurodegeneration
which is a characteristic phenotype linked to AD [30].
CDKs (CDK1, CDK2, and CDK5) have been associated
with tau hyperphosphorylation, amyloid precursor protein
processing, and apoptosis due to the cell cycle deregulation
in AD [31]. Therefore, the agents that block cyclins or
CDKs may further block neurodegeneration in AD patients
[32]. Thus, we can propose a hypothesis that variolins,
being inhibitors of CDKs, could block neurodegeneration
in AD. Consequently, this potential activity of variolins
could be tested for its effects in AD.
Furospongolide as an angiogenesis blocker
The term ‘furospongolide’ from “Sponge compounds”
dictionary is linked to vascular endothelial growth factor
‘VEGF’ from “Human genes and proteins” dictionary
through one PubMed record, while ‘VEGF’ is further
linked to ‘angiogenesis’ from “Disease concepts” dictionary
via 73 PubMed records. Thus, we have an indirect link
between ‘furospongolide’ and ‘angiogenesis’ (Figure 3).
Testing the co-occurrence of these two terms in the whole
PubMed retrieved no results. The in-depth analysis of the
mechanism of action of furospongolide reveals that this
Figure 3 Potential hypothesis linking ‘Furospongolide’ to ‘Angiogenesis’ via ‘Vascular endothelial growth factor’. The interactions are
based on co-occurrence of two entities in the relevant PubMed records.
Figure 4 Possible mechanisms of action of Furospongolide in a
tumor cell.
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spiratory chain mechanism, where it exerts an inhibitory
effect on mitochondrial respiratory chain complex I
without any effect on other complexes. Furospongolide
inhibits HIF-1 by suppressing tumor cell respiration via
NADH-ubiquinone oxidoreductase (complex I)-mediated
mitochondrial electron transfer [33]. The inhibition of
HIF-1 further leads to suppression of expression of several
genes that are activated by binding of HIF-1 on their
promoters [34,35]. Furospongolide also inhibits HIF-1
targeted vascular endothelial growth factor (VEGF). VEGF
is a key stimulant of tumor angiogenesis (formation of
new blood vessels that feeds cancerous cell growth) and
suppression of VEGF normally blocks the angiogenesis in
tumor cells [36]. Thus, the proposed hypothesis is that
furospongolide could be used as a drug to block angio-
genesis in tumors (Figure 4).
Conclusions
DESMSCI is the first publicly available knowledge base
where users can explore various types of information
about sponge natural products at chemical, biological and
molecular levels. Hypothesis generation is an important
component of this system and it can help researchers to
develop new ideas and test them by using the available
literature and other information repositories. We hopethat this knowledge base will serve as a useful comple-
ment to the existing public resources and for researchers
involved in natural products’ research at any level across
different disciplines.
Future directions
DESMSCI will be updated every six months and the infor-
mation from all new studies published in that period will
be incorporated. As the number of concepts grows with
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http://www.jcheminf.com/content/5/1/11new incoming literature, the dictionaries will also be
further curated and expanded. The improvement in the
quality of dictionaries will certainly enhance the accuracy
of the knowledge base. The comments obtained from
the users will also help to improve the functionality of
DESMSCI.
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